Propel Bio Partners L.P. 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-03-30 5:35 pm Sale |
2022-10-27 | 13G | Applied Therapeutics, Inc. APLT |
Propel Bio Partners L.P. | 1,234,519 2.570% |
-1,270,862![]() (-50.73%) |
Filing |
2023-02-14 2:39 pm Purchase |
2022-10-27 | 13G | Applied Therapeutics, Inc. APLT |
Propel Bio Partners L.P. | 2,505,381 5.210% |
2,505,381![]() (New Position) |
Filing |